PE20091177A1 - Compuestos heterociclicos antiviricos - Google Patents

Compuestos heterociclicos antiviricos

Info

Publication number
PE20091177A1
PE20091177A1 PE2008002137A PE2008002137A PE20091177A1 PE 20091177 A1 PE20091177 A1 PE 20091177A1 PE 2008002137 A PE2008002137 A PE 2008002137A PE 2008002137 A PE2008002137 A PE 2008002137A PE 20091177 A1 PE20091177 A1 PE 20091177A1
Authority
PE
Peru
Prior art keywords
chloro
fluor
phenoxy
benzyl
compounds
Prior art date
Application number
PE2008002137A
Other languages
English (en)
Inventor
Roland Joseph Billedeau
Zachary Kevin Sweeney
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40262294&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20091177(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20091177A1 publication Critical patent/PE20091177A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE X1 Y X2 SON CADA UNO H, N; R1 ES F, H; R2 ES H, HALOGENO, ALQUILO C1-C6, CICLOALQUILO C3-C7, HALOALQUILO C1-C6, ENTRE OTROS; Ar ES FENILO SUSTITUIDO O NO POR 1-3 GRUPOS SELECCIONADOS DE H, HALOGENO, CIANO, ALQUILO C1-C6, ENTRE OTROS; R3 ES CH2OH, CARBOXILATO DE METILO, ACETATO DE METILO, ACIDO ACETICO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS: SUCCINATO DE MONO-{3-[4-BROMO-3-(3-CLORO-5-CIANO-FENOXI)-2-FLUOR-BENCIL]-PIRAZOLO[3,4-b]PIRIDIN-1-ILMETILO}; 3-[4-BROMO-3-(3-CLORO-5-CIANO-FENOXI)-2-FLUOR-BENCIL]-PIRAZOLO[3,4-c]PIRIDAZINA-1-CARBOXILATO DE METILO; PENTANODIATODE MONO-{3-[4-CLORO-3-(3-CLORO-5-CIANO-FENOXI)-2-FLUOR-BENCIL]-PIRAZOLO[3,4-c]PIRIDAZIN-1-ILMETILO}; ENTRE OTROS. DICHOS COMPUESTOS INHIBEN LA TRANSCRIPTASA INVERSA DEL VIH-1 UTILES EN EL TRATAMIENTO DE INFECCIONES POR SIDA, ARC
PE2008002137A 2007-12-21 2008-12-18 Compuestos heterociclicos antiviricos PE20091177A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1614207P 2007-12-21 2007-12-21

Publications (1)

Publication Number Publication Date
PE20091177A1 true PE20091177A1 (es) 2009-08-03

Family

ID=40262294

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008002137A PE20091177A1 (es) 2007-12-21 2008-12-18 Compuestos heterociclicos antiviricos

Country Status (18)

Country Link
US (1) US8063028B2 (es)
EP (1) EP2225239B1 (es)
JP (1) JP5411160B2 (es)
KR (2) KR101610607B1 (es)
CN (1) CN101903382B (es)
AR (1) AR069789A1 (es)
AU (1) AU2008340422B2 (es)
BR (1) BRPI0821349A2 (es)
CA (1) CA2709348C (es)
CL (1) CL2008003786A1 (es)
ES (1) ES2526649T3 (es)
IL (1) IL205863A (es)
MX (1) MX2010006397A (es)
PE (1) PE20091177A1 (es)
RU (1) RU2495878C2 (es)
TW (1) TWI445533B (es)
WO (1) WO2009080534A1 (es)
ZA (1) ZA201003815B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090023737A1 (en) * 2004-02-12 2009-01-22 Neurogen Corporation Imidazo-Pyridazines, Triazolo-Pyridazines and Related Benzodiazepine Receptor Ligands
EP2001880A2 (en) * 2006-03-07 2008-12-17 Array Biopharma, Inc. Heterobicyclic pyrazole compounds and methods of use
CN101528702A (zh) * 2006-06-08 2009-09-09 阿雷生物药品公司 喹啉化合物和使用方法
DE102007026341A1 (de) 2007-06-06 2008-12-11 Merck Patent Gmbh Benzoxazolonderivate
DE102007032507A1 (de) 2007-07-12 2009-04-02 Merck Patent Gmbh Pyridazinonderivate
DE102007061963A1 (de) 2007-12-21 2009-06-25 Merck Patent Gmbh Pyridazinonderivate
DE102008019907A1 (de) 2008-04-21 2009-10-22 Merck Patent Gmbh Pyridazinonderivate
DE102008028905A1 (de) 2008-06-18 2009-12-24 Merck Patent Gmbh 3-(3-Pyrimidin-2-yl-benzyl)-[1,2,4]triazolo[4,3-b]pyridazinderivate
JP2012509342A (ja) 2008-11-20 2012-04-19 オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド 置換ピロロ［２，３−ｂ］−ピリジンおよび−ピラジン
KR101663335B1 (ko) 2008-12-22 2016-10-06 메르크 파텐트 게엠베하 6-（1-메틸-1ｈ-피라졸-4-일）-2-｛3-［5-（2-모르폴린-4-일-에톡시）-피리미딘-2-일］-벤질｝-2ｈ-피리다진-3-온디히드로겐포스페이트의 신규한 다형체 및 이의 제조 방법
US20120232062A1 (en) * 2009-10-20 2012-09-13 Eiger Biopharmaceuticals, Inc. Azaindazoles to treat flaviviridae virus infection
JP2013511489A (ja) 2009-11-21 2013-04-04 エフ．ホフマン−ラ ロシュ アーゲー 複素環式抗ウイルス化合物
AR081039A1 (es) 2010-05-14 2012-05-30 Osi Pharmaceuticals Llc Inhibidores biciclicos fusionados de quinasa
US20130072495A1 (en) * 2010-05-14 2013-03-21 OSI Pharmaceuticals, LLC Fused bicyclic kinase inhibitors
US10872283B2 (en) 2018-10-31 2020-12-22 United Services Automobile Association (Usaa) Wireless communications device with concealed value
AR117169A1 (es) * 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas
CN111153775B (zh) * 2020-01-16 2023-04-28 江苏理工学院 一种三氯生甲酯的制备方法

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4949314A (en) 1966-08-16 1990-08-14 The United States Of America As Represented By The Secretary Of The Navy Method and means for increasing echo-ranging-search rate
US4518584A (en) 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
GB8327880D0 (en) 1983-10-18 1983-11-16 Ajinomoto Kk Saccharomyces cerevisiae
US4569790A (en) 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4604377A (en) 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
US4530787A (en) 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
IL76360A0 (en) 1984-09-26 1986-01-31 Takeda Chemical Industries Ltd Mutual separation of proteins
US4752585A (en) 1985-12-17 1988-06-21 Cetus Corporation Oxidation-resistant muteins
US4748234A (en) 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
AU622926B2 (en) 1988-09-09 1992-04-30 Nippon Kayaku Kabushiki Kaisha Pyrimidine or purine cyclobutane derivatives
US5925643A (en) 1990-12-05 1999-07-20 Emory University Enantiomerically pure β-D-dioxolane-nucleosides
US5489697A (en) 1994-08-03 1996-02-06 Medichem Research, Inc. Method for the preparation of (+)-calanolide A and intermediates thereof
BR9509024A (pt) 1994-09-26 1997-09-30 Shionogi & Co Derivados de imidazol
IL117574A0 (en) 1995-04-03 1996-07-23 Bristol Myers Squibb Co Processes for the preparation of cyclobutanone derivatives
GB0016787D0 (en) 2000-07-07 2000-08-30 Pfizer Ltd Compounds useful in therapy
GB0024795D0 (en) 2000-10-10 2000-11-22 Hoffmann La Roche Pyrazole derivatives for the treatment of viral diseases
CZ305099B6 (cs) 2001-04-10 2015-05-06 Pfizer Inc. Derivát pyrazolu, způsoby a meziprodukty pro výrobu, farmaceutická kompozice s jeho obsahem a jeho lékařské aplikace, zejména k léčení infekcí HIV
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
GB0124848D0 (en) * 2001-10-16 2001-12-05 Celltech R&D Ltd Chemical compounds
ATE318140T1 (de) 2001-10-26 2006-03-15 Angeletti P Ist Richerche Bio N-substituierte hydroxypyrimidinoncarboxamid- hemmer der hiv-integrase
FR2841551B1 (fr) 2002-06-28 2006-01-13 Rhodia Chimie Sa Procede de synthese de derives a radical hydrogenofluoromethylene-sulfonyle
EP1546132A1 (en) 2002-09-26 2005-06-29 Pfizer Limited Pyrazole derivatives as reverse transcriptase inhibitors
GB0223232D0 (en) 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
GB0223234D0 (en) 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
TW200505441A (en) * 2003-03-24 2005-02-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitorsⅠ
WO2004085406A1 (en) * 2003-03-24 2004-10-07 F. Hoffmann-La Roche Ag Benzyl-pyridazinons as reverse transcriptase inhibitors
CN1934092A (zh) * 2004-03-23 2007-03-21 弗·哈夫曼-拉罗切有限公司 非核苷逆转录酶抑制剂
US7166738B2 (en) * 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
US7625949B2 (en) * 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
RU2394028C2 (ru) * 2004-07-27 2010-07-10 Ф.Хоффманн-Ля Рош Аг Производные бензилтриазолона в качестве ненуклеозидных ингибиторов обратной транскриптазы
CA2577144C (en) * 2004-09-30 2011-06-21 Boehringer Ingelheim International Gmbh Alkynyl compounds as non-nucleoside reverse transcriptase inhibitors
AU2005317735B2 (en) 2004-12-21 2009-06-04 Pfizer Products Inc. Macrolides
US20090264425A1 (en) 2004-12-22 2009-10-22 Pfizer Limited Chemical compounds
JP2008534456A (ja) * 2005-03-24 2008-08-28 エフ．ホフマン−ラ ロシュ アーゲー ヘテロ環式逆転写酵素インヒビターとしての１，２，４−トリアゾール−５−オン化合物
AR057455A1 (es) * 2005-07-22 2007-12-05 Merck & Co Inc Inhibidores de la transcriptasa reversa de vih y composicion farmaceutica
AU2006298853A1 (en) * 2005-09-30 2007-04-12 F. Hoffmann-La Roche Ag NNRT inhibitors
WO2007045572A1 (en) * 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
KR20080056220A (ko) * 2005-10-19 2008-06-20 에프. 호프만-라 로슈 아게 페닐-아세트아마이드 ｎｎｒｔ 저해제
EP1965796A2 (en) * 2005-12-20 2008-09-10 Gilead Colorado, Inc. 4,7-dihydrothieno[2,3-b]pyridine compounds and pharmaceutical compositions
AU2007286345B2 (en) * 2006-08-16 2012-03-08 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
AU2008235549A1 (en) * 2007-04-09 2008-10-16 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors

Also Published As

Publication number Publication date
KR20150070440A (ko) 2015-06-24
US8063028B2 (en) 2011-11-22
EP2225239B1 (en) 2014-10-22
ZA201003815B (en) 2011-02-23
US20090170856A1 (en) 2009-07-02
CA2709348C (en) 2016-07-19
KR20100095606A (ko) 2010-08-31
CN101903382A (zh) 2010-12-01
CA2709348A1 (en) 2009-07-02
MX2010006397A (es) 2010-07-05
BRPI0821349A2 (pt) 2019-09-24
JP5411160B2 (ja) 2014-02-12
JP2011506535A (ja) 2011-03-03
TWI445533B (zh) 2014-07-21
TW200930372A (en) 2009-07-16
AU2008340422A1 (en) 2009-07-02
AU2008340422B2 (en) 2014-06-19
CN101903382B (zh) 2012-11-28
IL205863A0 (en) 2010-11-30
AR069789A1 (es) 2010-02-17
IL205863A (en) 2016-08-31
RU2010129548A (ru) 2012-01-27
CL2008003786A1 (es) 2010-02-19
RU2495878C2 (ru) 2013-10-20
EP2225239A1 (en) 2010-09-08
KR101610415B1 (ko) 2016-04-07
WO2009080534A1 (en) 2009-07-02
ES2526649T3 (es) 2015-01-14
KR101610607B1 (ko) 2016-04-07

Similar Documents

Publication Publication Date Title
PE20091177A1 (es) Compuestos heterociclicos antiviricos
PE20120629A1 (es) Compuesto triazolopiridina y su accion como inhibidor de prolil hidroxilasa e inductor de la produccion de eritropoyetina
PE20051141A1 (es) Inhibidores de la polimerasa viral
PE20071326A1 (es) Inhibidores de la polimerasa viral
PE20090290A1 (es) Derivados de pirrolopiridina como inhibidores de bace
JO2643B1 (en) Derivatives of 2-aryl-6-phenylimidazole [a-1,2] pyridine, their preparation and therapeutic use
PE20051159A1 (es) Derivados de heteroarilaminopirazol como estimulantes de la produccion de insulina
PE20050864A1 (es) Compuestos de heterociclilamino como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1
PE20090609A1 (es) Compuestos de pirazol para controlar plagas de invertebrados
PE20070810A1 (es) Compuestos derivados de benzoilpirazol como herbicidas
PE20070814A1 (es) Compuestos derivados de 2-carboxitiofeno como inhibidores de la polimerasa del virus de la hepatitis c (hcv)
AR062224A1 (es) Tetrazolilos macrociclicos como inhibidores de serina proteasa ns3 del virus de hepatitis c y composiciones farmaceuticas que los comprenden.
AR055563A1 (es) Compuestos de piridil acido acetico, agente farmaceutico y utilizacion del compuesto para preparar dicho agente
MX2009010024A (es) Nuevo compuesto de adenina.
PE20090601A1 (es) Derivados de piridin-il-oxi-piridinas como inhibidores de alk5
PE20100737A1 (es) Nuevos compuestos
PE20091818A1 (es) DERIVADOS POLISUSTITUIDOS DE 2-ARIL-6-FENIL-IMIDAZO[1,2-a] PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
TN2009000199A1 (en) Heteromonocyclic compound and use thereof
PE20050747A1 (es) Pirimidinas herbicidas
PE20070051A1 (es) Serin-amidas sustituidas con heteroaroilo
PE20050689A1 (es) Inhibidores de quinasas
PE20121047A1 (es) Derivados de tiazolilpiperidina como fungicidas
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
AR059328A1 (es) Derivados de antranilamida-2-amino-heteroareno-carboxamida, un proceso para su obtencion, composiciones farmaceuticas que los contienen y el uso de estos compuestos para la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por cetp
EA201600403A1 (ru) N-ацилиминогетероциклические соединения

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed